IL88731A0 - Non-reverting rna viruses - Google Patents

Non-reverting rna viruses

Info

Publication number
IL88731A0
IL88731A0 IL88731A IL8873188A IL88731A0 IL 88731 A0 IL88731 A0 IL 88731A0 IL 88731 A IL88731 A IL 88731A IL 8873188 A IL8873188 A IL 8873188A IL 88731 A0 IL88731 A0 IL 88731A0
Authority
IL
Israel
Prior art keywords
reverting
rna viruses
vaccines
relates
rna viral
Prior art date
Application number
IL88731A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL88731A0 publication Critical patent/IL88731A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
IL88731A 1988-01-11 1988-12-20 Non-reverting rna viruses IL88731A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14250788A 1988-01-11 1988-01-11

Publications (1)

Publication Number Publication Date
IL88731A0 true IL88731A0 (en) 1989-07-31

Family

ID=22500099

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88731A IL88731A0 (en) 1988-01-11 1988-12-20 Non-reverting rna viruses

Country Status (9)

Country Link
EP (1) EP0325768B1 (da)
JP (1) JPH01222774A (da)
AT (1) ATE121779T1 (da)
AU (1) AU2833789A (da)
DE (1) DE3853672T2 (da)
DK (1) DK8789A (da)
ES (1) ES2070846T3 (da)
FI (1) FI890116A7 (da)
IL (1) IL88731A0 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286640A (en) * 1988-01-05 1994-02-15 Almond Jeffrey W Attenuated polioviruses
US5298416A (en) * 1989-01-18 1994-03-29 British Technology Group Ltd. Attenuated polioviruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
EP0401421B1 (en) * 1989-06-08 1996-01-03 American Cyanamid Company Non-reverting RNA viruses
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
US6853093B2 (en) 2002-12-20 2005-02-08 Lipman Electronic Engineering Ltd. Anti-tampering enclosure for electronic circuitry
US8405506B2 (en) 2010-08-02 2013-03-26 Verifone, Inc. Secure data entry device
US8593824B2 (en) 2010-10-27 2013-11-26 Verifone, Inc. Tamper secure circuitry especially for point of sale terminal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
JPS59173084A (ja) * 1982-11-30 1984-09-29 インステイチユ−ト・パスツ−ル ポリオウイルスの免疫原性部位よりなるペプチド類及びこれらのペプチド類を暗合化するヌクレオチド配列を含有するdna類
EP0156299A3 (en) * 1984-03-26 1987-04-01 Chiron Corporation Ltr modified viral vaccines

Also Published As

Publication number Publication date
DK8789A (da) 1989-07-12
ATE121779T1 (de) 1995-05-15
FI890116L (fi) 1989-07-12
DE3853672T2 (de) 1996-01-11
DE3853672D1 (de) 1995-06-01
EP0325768B1 (en) 1995-04-26
EP0325768A3 (en) 1989-08-30
EP0325768A2 (en) 1989-08-02
ES2070846T3 (es) 1995-06-16
AU2833789A (en) 1989-07-13
FI890116A0 (fi) 1989-01-10
FI890116A7 (fi) 1989-07-12
DK8789D0 (da) 1989-01-10
JPH01222774A (ja) 1989-09-06

Similar Documents

Publication Publication Date Title
ATE129160T1 (de) Herpes-simplex-impfstoff, der hsv-glycoprotein-gd und 3-deacyl monophosphoryl-lipid-a enthaelt.
AU3636189A (en) Hiv-2 virus variants
FR09C0033I1 (da)
HUT66437A (en) A composition used as a therapeutic agent against chronic viral hepatic diseases
DE3485873D1 (en) Herpes simplex virus subunitimpfstoff.
PT84155A (en) Method of modifying plant viruses or their effects
EP0325768A3 (en) Non-reverting rna viruses
ES2053953T3 (es) Uso de fracciones de heparina o fragmentos de heparina.
AR242057A1 (es) Poliovirus quimerico viable, cdna recombinante hibrido apto para su produccion en un cultivo de celulas, y procedimiento para la obtencion de dicho poliovirus.
AU630099B2 (en) Non-reverting rna viruses
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
AU6163590A (en) Mutant pseudorabies virus, and vaccines containing the same
IL81568A0 (en) Plasmids which inhibit human t-cell lymphotropic virus type iii replication
AU653861B2 (en) Respiratory disease vaccine for cats
FR2671974B1 (da)
IL106275A0 (en) Non-reverting rna viruses
DE58902715D1 (de) Steckbarer kochherdschutzschild zur verhuetung von kinderunfaellen.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
NO891355D0 (no) Vaksinasjon mot rabis-beslektede virus.
GB8712042D0 (en) Virus & vaccine